# A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects

> **NCT04164290** · PHASE1 · COMPLETED · sponsor: **Tasly Pharmaceutical Group Co., Ltd** · enrollment: 70 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets
- **DRUG:** Jiashen Tablets Placebo
- **DRUG:** Jiashen Tablets Placebo
- **DRUG:** Jiashen Tablets Placebo
- **DRUG:** Jiashen Tablets Placebo
- **DRUG:** Jiashen Tablets Placebo
- **DRUG:** Jiashen Tablets Placebo

## Key facts

- **NCT ID:** NCT04164290
- **Lead sponsor:** Tasly Pharmaceutical Group Co., Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-29
- **Primary completion:** 2021-04-09
- **Final completion:** 2021-04-09
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2022-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04164290

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04164290, "A Study to Evaluate the Tolerability and Pharmacokinetics of Jiashen Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04164290. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*